Cargando…

Efficacy and safety of early tacrolimus conversion to sirolimus after kidney transplantation: Long-term results of a prospective randomized study

We report a prospective, open-label, randomized study to evaluate the safety and efficacy of converting patients with a stable renal function from tacrolimus (Tac)-based regimen to a sirolimus (SRL)-based regimen after kidney transplantation. Fifty-eight low-risk renal allograft recipients who recei...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Agroudy, A. E., Alarrayed, S. M., Al-Ghareeb, S. M., Farid, E., Alhelow, H., Abdulla, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5255987/ https://www.ncbi.nlm.nih.gov/pubmed/28182044 http://dx.doi.org/10.4103/0971-4065.176146

Ejemplares similares

Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus
por: Gallon, Lorenzo, et al.
Publicado: (2014)

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
por: Yu, Ji Hyun, et al.
Publicado: (2016)

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002)

Systematic conversion to generic tacrolimus in stable kidney transplant recipients
por: Rosenborg, Staffan, et al.
Publicado: (2014)

Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
por: Veroux, Massimiliano, et al.
Publicado: (2013)

Mycophenolate Mofetil Enhances the Negative Effects of Sirolimus and Tacrolimus on Rat Kidney Cell Metabolism
por: Klawitter, Jelena, et al.
Publicado: (2014)

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype
por: Carroll, Robert P., et al.
Publicado: (2013)

A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk
por: Lee, Juhan, et al.
Publicado: (2015)

Effectiveness and safety of the conversion to MeltDose(®) extended‐release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study
por: Sánchez Fructuoso, Ana, et al.
Publicado: (2019)

A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation
por: Kasiske, Bertram L., et al.
Publicado: (2012)

Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine
por: Silva, Jacqueline D., et al.
Publicado: (2023)

Autophagy in kidney transplants of sirolimus treated recipients
por: Bhayana, Sagar, et al.
Publicado: (2017)

Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
por: Wagle Shukla, Aparna, et al.
Publicado: (2023)

Efficacy of Prolonged-release Tacrolimus After Conversion From Immediate-release Tacrolimus in Kidney Transplantation: A Retrospective Analysis of Long-term Outcomes From the ADMIRAD Study
por: Kuypers, Dirk, et al.
Publicado: (2023)

Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
por: Jeon, Hee Jung, et al.
Publicado: (2018)

CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
por: Li, Yi, et al.
Publicado: (2015)

Sirolimus vs tacrolimus: Which one is the best therapeutic option for patients undergoing liver transplantation for hepatocellular carcinoma?
por: Ahmed, Faiza, et al.
Publicado: (2022)

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
por: Son, Seung Yeon, et al.
Publicado: (2017)

Sirolimus-Induced Rash in a Kidney Transplant Patient
por: Bruss, Zachary, et al.
Publicado: (2022)

Safety and Efficacy of Conversion from Twice-Daily Tacrolimus to Once-Daily Tacrolimus One Month after Transplantation: Randomized Controlled Trial in Adult Renal Transplantation
por: Oh, Chang-Kwon, et al.
Publicado: (2014)

Effects of metformin on hyperglycemia in an experimental model of tacrolimus- and sirolimus-induced diabetic rats
por: Jin, Jian, et al.
Publicado: (2017)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021)

A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes
por: Riegersperger, Markus, et al.
Publicado: (2019)

Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells
por: Traitanon, Opas, et al.
Publicado: (2015)

Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant
por: Wijesinha, Marniker, et al.
Publicado: (2019)

Pilot Analysis of Late Conversion to Belatacept in Kidney Transplant Recipients for Biopsy-Proven Chronic Tacrolimus Toxicity
por: Gupta, Shruti, et al.
Publicado: (2018)

Conversion from tacrolimus to belatacept improves renal function in kidney transplant patients with chronic vascular lesions in allograft biopsy
por: Pérez-Sáez, María José, et al.
Publicado: (2018)

Drug Interaction between Sirolimus and Ranolazine in a Kidney Transplant Patient
por: Masters, Joanna C., et al.
Publicado: (2014)

Prevalence of Musculoskeletal Manifestations in Adult Kidney Transplant’s Recipients: A Systematic Review
por: Hassan, Adla B., et al.
Publicado: (2021)

Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients
por: Francke, M. I., et al.
Publicado: (2022)

Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients
por: Burke, Michael Thomas, et al.
Publicado: (2017)

In Vitro Interaction between Isavuconazole and Tacrolimus, Cyclosporin A, or Sirolimus against Aspergillus Species
por: Schwarz, Patrick, et al.
Publicado: (2020)

Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
por: Lee, John R., et al.
Publicado: (2015)

Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation
por: Yu, Meng, et al.
Publicado: (2018)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended‐release tacrolimus preparation
por: El‐Nahhas, Toqa, et al.
Publicado: (2021)

Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
por: Foroutan, Naghmeh, et al.
Publicado: (2013)

Effect of sirolimus on carotid atherosclerosis in kidney transplant recipients: data derived from a prospective randomized controlled trial
por: Silva, Andre L, et al.
Publicado: (2018)

Conversion from Standard-Release Tacrolimus to MeltDose(®) Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
por: von Einsiedel, Johannes, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t59m3q5jfkk5b7bk0nrnrfl42c